Inventor · disambiguated record
Jiali Li
Also filed as: LI JIALI
3 granted patents·15 pending applications·6 citations·filing 2004–2025
62Inventor score
Files withRECURIUM IP HOLDINGS LLC12EPSTEIN ALAN L3BEIJING DIDI INFINITY TECHNOLOGY & DEV CO LTD1GUANGZHOU HANFANG PHARMACEUTICAL CO LTD1ZENO MAN INC1
Top patents by PatentIndex Score
18 records- 0181US11278532B2Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2020·Granted Mar 22, 2022·1 cites·22 claims
- 0281US8545838B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2007·Granted Oct 1, 2013·3 cites·46 claims
- 0373US8795672B2Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2004·Granted Aug 5, 2014·2 cites·7 claims
- 0464US2024325397A1Use of combination therapy for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2024·Application pending·0 cites
- 0562US2014099305A1Compositions and methods for cancer immunotherapyEPSTEIN ALAN L·Filed 2013·Application pending·0 cites
- 0661US2024408097A1Wee1 inhibitors and methods for treating cancerRECURIUM IP HOLDINGS LLC·Filed 2023·Application pending·0 cites
- 0761US2022125769A1Estrogen receptor modulators for treating mutantsRECURIUM IP HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 0854US2023210854A1Mono- and combination therapiesRECURIUM IP HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 0952US2023054854A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1052US2023068370A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1151US2023054767A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1251US2023008362A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1350US2023042653A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1450US2023053946A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1549US2023087941A1CombinationsRECURIUM IP HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 1646US2025262214A1Intermittent dosing regimen for azenosertib in treating cancerZENO MAN INC·Filed 2025·Application pending·0 cites
- 1745US2024270781A1Preparation method of paeoniflorin-6'-o-benzene sulfonateGUANGZHOU HANFANG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1839US2019122546A1Systems and methods for analyzing and adjusting road conditionsBEIJING DIDI INFINITY TECHNOLOGY & DEV CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiali Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →